Gene · 409
Papers2,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) "Cis-On" Agonist. | ACS Chem Neurosci | 2022 | 35881914 | PubTator, text mining | PubMed |
| Agonist concentration-dependent changes in FPR1 conformation lead to biased signaling for selective activation of phagocyte functions. | Proc Natl Acad Sci U S A | 2022 | 35878025 | PubTator, text mining | PubMed |
| The Long Non-coding RNA AC148477.2 Is a Novel Therapeutic Target Associated With Vascular Smooth Muscle Cells Proliferation of Femoral Atherosclerosis. | Front Cardiovasc Med | 2022 | 35872920 | PubTator, text mining | PubMed |
| Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status. | Elife | 2022 | 35866628 | PubTator, text mining | PubMed |
| G protein-coupled receptor interactions with arrestins and GPCR kinases: The unresolved issue of signal bias. | J Biol Chem | 2022 | 35863432 | PubTator, text mining | PubMed |
| GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation. | Cell Rep | 2022 | 35858570 | PubTator, text mining | PubMed |
| Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity. | SLAS Discov | 2022 | 35850480 | PubTator, text mining | PubMed |
| Structural Elements Directing G Proteins and β-Arrestin Interactions with the Human Melatonin Type 2 Receptor Revealed by Natural Variants. | ACS Pharmacol Transl Sci | 2022 | 35846981 | PubTator, text mining | PubMed |
| The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review. | Pharmgenomics Pers Med | 2022 | 35795337 | PubTator, text mining | PubMed |
| Lysyl oxidase promotes renal fibrosis via accelerating collagen cross-link driving by β-arrestin/ERK/STAT3 pathway. | FASEB J | 2022 | 35792886 | PubTator, text mining | PubMed |
| LncRNA GATA3-AS1 promoted invasion and migration in human endometrial carcinoma by regulating the miR-361/ARRB2 axis. | J Mol Med (Berl) | 2022 | 35788718 | PubTator, text mining | PubMed |
| Characterization of lncRNA-Based ceRNA Network and Potential Prognostic Hub Genes for Sepsis. | Evid Based Complement Alternat Med | 2022 | 35774747 | PubTator, text mining | PubMed |
| β-Arrestin 2 and Epac2 Cooperatively Mediate DRD1-Stimulated Proliferation of Human Neural Stem Cells and Growth of Human Cerebral Organoids. | Stem Cells | 2022 | 35772103 | PubTator, text mining | PubMed |
| Emerging structural insights into GPCR-β-arrestin interaction and functional outcomes. | Curr Opin Struct Biol | 2022 | 35738165 | PubTator, text mining | PubMed |
| Epidemiological Characteristics of OXA-232-Producing Carbapenem-Resistant Klebsiella pneumoniae Strains Isolated during Nosocomial Clonal Spread Associated with Environmental Colonization. | Microbiol Spectr | 2022 | 35730968 | PubTator, text mining | PubMed |
| The Mechanism and Function of Glia in Parkinson's Disease. | Front Cell Neurosci | 2022 | 35722618 | PubTator, text mining | PubMed |
| Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor. | Front Endocrinol (Lausanne) | 2022 | 35721749 | PubTator, text mining | PubMed |
| DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells. | Front Endocrinol (Lausanne) | 2022 | 35721701 | PubTator, text mining | PubMed |
| Characterization of metal(loid)s and antibiotic resistance in bacteria of human gut microbiota from chronic kidney disease subjects. | Biol Res | 2022 | 35715831 | PubTator, text mining | PubMed |
| Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting. | Sci Transl Med | 2022 | 35704598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/409/papers?page=18